SIRPA and neoplasm: Irradiation damages the tumor tissues and increases infiltration and SIRPα expression on MDSCs, and combined with azelnidipine that blocks CD47/SIRPα interaction, it can enhance MDSC cell-mediated phagocytosis of tumor cells, thereby remarkably inhibiting the tumor growth.